4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-22-002893
Options or other derivatives
- See Remarks acquired 131,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Symons Julian A. See Remarks | 2022-02-04 | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | D | ||
| Symons Julian A. See Remarks | 2022-02-04 | Grant or award · Stock Option (Right to Buy) | +26,250 | 26,250 | D | ||
Loading xslF345X03/doc1.xml…